I have started a Parliamentary complaint process under advice of progression to criminal investigation against the MHRA.
This is due to failures to respond to evidence for justification for the provision of 'marketing authorisation' to Nuvaxoid, and will then lead into other 'authorisations', as the MHRA have failed to provide the evidence required.
At the right point I will open up the complaint to other signatories and input from relevant sources, external to the whitewash that will be the 'inquiry'.
The argument has never changed, and it is based on burden of proof, and the neglect based around Nuvaxiod opens the door to wider route to recourse as yet explored.